$4.08
-0.17 (-4.00%)
MELA Sciences (NASDAQ:MELA)
CAPS Rating:
A medical device company which focuses on designing and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma.
RSS Headlines
Fool UK